Toshiba ships 300th Opart

Article

An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed

An MRI milestone was reached in mid-December when Toshiba America Medical Systems shipped its 300th Opart MRI scanner. The superconducting open system with a field strength of 0.35 tesla entered the market some three years ago. It was designed specifically for the U.S. marketplace, where most have been sold. Ironically, the 300th unit was delivered to Toshiba Medical Systems Europe, which will install the product at a site in Italy.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.